Browsing by Author Finer, Nick

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 19 of 19
Issue DateTitleAuthor(s)Citation
2009Acute effect of weight loss on levels of total bilirubin in obese, cardiovascular high-risk patients: an analysis from the lead-in period of the Sibutramine Cardiovascular Outcome trialCaterson, Ian; Andersson, Charlotte; Brendorp, Bente; Coutinho, Walmir; Finer, Nick; Fosbol, Emil Loldrup; Kober, Lars; Sharma, Arya; Van Gaal, L; Weeke, Peter; Boden InstituteAcute effect of weight loss on levels of total bilirubin in obese, cardiovascular high-risk patients: an analysis from the lead-in period of the Sibutramine Cardiovascular Outcome trial, Metabolism: clinical and experimental, vol.58, 8, 2009,pp 1109-1115
2007Additive effects of weight loss and sibutramine in managing hypertensive patients - An analysis of the sibutramine cardiovascular outcomes (SCOUT) trialCaterson, Ian; Coutinho, Walmir; Finer, Nick; James, P; Maggioni, Aldo Pietro; Sharma, Arya M; Torp-Pedersen, Christian; Van Gaal, L; School of Molecular BioscienceAdditive effects of weight loss and sibutramine in managing hypertensive patients - An analysis of the sibutramine cardiovascular outcomes (SCOUT) trial, Journal of Hypertension. Supplement, vol.25,(N/A),2007,pp S290-S290
2013Association of hypoglycemic treatment regimens with cardiovascular outcomes in overweight and obese subjects with type 2 diabetes: A substudy of the SCOUT trialCaterson, Ian; Andersson, Charlotte; Coutinho, Walmir; Finer, Nick; Ghotbi, Adam; James, W; Køber, Lars; Sharma, Arya; Torp-Pedersen, Christian; Van Gaal, Luc; Boden InstituteAssociation of hypoglycemic treatment regimens with cardiovascular outcomes in overweight and obese subjects with type 2 diabetes: A substudy of the SCOUT trial, Diabetes Care, vol.36, 11, 2013,pp 3746-3753
2009Blood pressure changes associated with sibutramine and weight management - an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes trial (SCOUT)Caterson, Ian; Bacher, H; Coutinho, Walmir; Finer, Nick; James, W; Maggioni, Aldo; Sharma, Arya; Shepherd, Gillian; Torp-Pedersen, Christian; Van Gaal, L; Boden InstituteBlood pressure changes associated with sibutramine and weight management - an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes trial (SCOUT), Diabetes, Obesity and Metabolism, vol.11, N/A, 2009,pp 239-250
2015Changes in body weight and pulse: outcome events in overweight and obese subjects with cardiovascular disease in the SCOUT trialCaterson, Ian; Espinoza, David; Gebski, Val; Seimon, Radhika; Sweeting, Arianne Natasha; Coutinho, Walmir; Finer, Nick; James, W; Legler, U F; Maggioni, Aldo; Sharma, Arya; Torp-Pedersen, Christian; Van Gaal, Luc; Boden Institute; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Boden Institute; Boden InstituteChanges in body weight and pulse: outcome events in overweight and obese subjects with cardiovascular disease in the SCOUT trial, International Journal of Obesity, vol.39, 5, 2015,pp 849-857
2009Differential changes in serum uric acid concentrations in sibutramine promoted weight loss in diabetes: results from four weeks of the lead-in period of the SCOUT trialCaterson, Ian; Anderson, Charlotte; Brendorp, Bente; Finer, Nick; Fosbøl, Emil; James, Philip; Køber, Lars; Rode, Richard; Sharma, Arya; Torp-Pedersen, Christian; Weeke, Peter; School of Molecular BioscienceDifferential changes in serum uric acid concentrations in sibutramine promoted weight loss in diabetes: results from four weeks of the lead-in period of the SCOUT trial, Nutrition & Metabolism, vol.6, 42,pp 9-N/A
2010Early Response to Sibutramine in Patients Not Meeting Current Label Criteria: Preliminary Analysis of SCOUT Lead-in PeriodCaterson, Ian; Coutinho, Walmir; Finer, Nick; Ge, Hong; James, Philip; Maggioni, Aldo; Santoro, Donatella; Sharma, Arya; Shepherd, Gillian; Torp-Pedersen, Christian; Van Gaal, Luc; Boden InstituteEarly Response to Sibutramine in Patients Not Meeting Current Label Criteria: Preliminary Analysis of SCOUT Lead-in Period, Obesity, vol.18, 5, 2010,pp 987-994
2010Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese SubjectsCaterson, Ian; Coutinho, Walmir; Finer, Nick; James, W; Maggioni, Aldo Pietro; Renz, Cheryl; Rode, Richard; Sharma, Arya; Shepherd, Gillian; Torp-Pedersen, Christian; Van Gaal, Luc; School of Molecular BioscienceEffect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects, New England Journal of Medicine, vol.363, 10,pp 905-917
2006Emerging pharmacotherapy for treating obesity and associated cardiometabolic risk.Caterson, Ian; Finer, Nick; Molecular & Microbial BioscienEmerging pharmacotherapy for treating obesity and associated cardiometabolic risk., Asia Pacific Journal of Clinical Nutrition, vol.15,(Supplement),2006,pp 55-62
2010Impact of Waist Circumference Difference on Health-Care Cost among Overweight and Obese Subjects: The PROCEED CohortCaterson, Ian; Aronne, L J; Coste, Florence; Despres, J P; Finer, Nick; Hauner, H; Hill, J O; Pendergast, K B; Sherrill, B H; Van Gaal, Luc; Wolf, A M; Zhou, Xiaolei; School of Molecular BioscienceImpact of Waist Circumference Difference on Health-Care Cost among Overweight and Obese Subjects: The PROCEED Cohort, Value in Health, vol.13, 4,pp 402-410
2007Initial blood pressure response of high-risk patients with diabetes plus cardioavascular disease after 6-weeks Sibutramine treatment - an analysis of the Sibutramine Cardiovascular Outcomes (SCOUT) TrialCaterson, Ian; Coutinho, W; Finer, Nick; James, W. P. T.; Maggioni, Aldo Pietro; Sharma, A; Torp-Pedersen, C; Van Gaal, L; Molecular & Microbial BioscienInitial blood pressure response of high-risk patients with diabetes plus cardioavascular disease after 6-weeks Sibutramine treatment - an analysis of the Sibutramine Cardiovascular Outcomes (SCOUT) Trial, Diabetologia: clinical and experimental diabetes and metabolism, vol.50,(suppl1),2007,pp s346-s346
2012Maintained Intentional Weight Loss Reduces Cardiovascular Outcomes: Results from the Sibutramine Cardiovascular OUTcomes (SCOUT) TrialCaterson, Ian; Coutinho, Walmir; et al, various; Finer, Nick; Legler, U; Maggioni, Aldo; Rode, Richard; Sharma, Arya; Shepherd, Gillian; Torp-Pedersen, Christian; Van Gaal, Luc; Molecular BioscienceMaintained Intentional Weight Loss Reduces Cardiovascular Outcomes: Results from the Sibutramine Cardiovascular OUTcomes (SCOUT) Trial, Diabetes, Obesity and Metabolism, vol.14, 6, 2012,pp 523-530
2012Obesity treatment for adults, adolescents and childrenBaur, Louise; Caterson, Ian; Steinbeck, Katharine (Kate); Finer, Nick; Children's Hospital Westmead: Paediatrics & Child Health; Boden Institute; Children's Hospital Westmead: Paediatrics & Child HealthObesity treatment for adults, adolescents and children in A Modern Epidemic: Expert Perspectives on Obesity and Diabetes, Sydney University Press, 2012, pp. 372-400
2008PROCEED: Prospective Obesity Cohort of Economic Evaluation and Determinants: baseline health and healthcare utilization of the US sampleCaterson, Ian; Allshouse, A A; Amand, C; Aronne, L J; Despres, J P; Finer, Nick; Hauner, H; Hill, J O; Pendergast, K B; Radigue, C; Sherrill, B H; Wolf, A M; Molecular & Microbial BioscienPROCEED: Prospective Obesity Cohort of Economic Evaluation and Determinants: baseline health and healthcare utilization of the US sample, Diabetes, Obesity & Metabolism, vol.10,(12),2008,pp 1248-1260
2017Relation between weight loss and causes of death in patients with cardiovascular disease: Finding from the SCOUT trialCaterson, Ian; Seimon, Radhika; Sweeting, Arianne Natasha; Coutinho, Walmir; Finer, Nick; James, W; Legler, U; Maggioni, Aldo; Sharma, Arya; Torp-Pedersen, Christian; Urso, Renato; Van Gaal, Luc; Boden Institute; Boden Institute; Boden InstituteRelation between weight loss and causes of death in patients with cardiovascular disease: Finding from the SCOUT trial, Journal of Cardiovascular Medicine (Hagerstown), vol.18, 3, 2017,pp 144-151
2012Relationship between HbA1c levels and risk of cardiovascular adverse outcomes and all-cause mortality in overweight and obese cardiovascular high-risk women and men with type 2 diabetesCaterson, Ian; Andersson, Charlotte; Couthino, W.; Finer, Nick; James, W; Maggioni, Aldo; Sharma, Arya; Torp-Pedersen, Christian; Van Gaal, L; Weeke, Peter; Boden InstituteRelationship between HbA1c levels and risk of cardiovascular adverse outcomes and all-cause mortality in overweight and obese cardiovascular high-risk women and men with type 2 diabetes, Diabetologia: clinical and experimental diabetes and metabolism, vol.55, 9, 2012,pp 2348-2355
2008Tolerability of Sibutramine During a 6-week Treatment Period in High-Risk Patients With Cardiovascular Disease and/or Diabetes: A Preliminary Analysis of the Sibutramine Cardiovascular Outcomes (SCOUT) TrialCaterson, Ian; Bacher, Peter; Coutinho, Walmir; Finer, Nick; James, Philip; Maggioni, Aldo; Sharma, Arya; Shepherd, Gillian; Sun, Rui; Torp-Pedersen, Christian; Van Gaal, Luc; Boden InstituteTolerability of Sibutramine During a 6-week Treatment Period in High-Risk Patients With Cardiovascular Disease and/or Diabetes: A Preliminary Analysis of the Sibutramine Cardiovascular Outcomes (SCOUT) Trial, Journal of Cardiovascular Pharmacology, vol.52, 5, 2008,pp 393-402
2013Uric Acid as a Risk Factor for Cardiovascular Disease and Mortality in Overweight/Obese IndividualsCaterson, Ian; Andersson, Charlotte; Coutinho, Walmir; Finer, Nick; James, W; Maggioni, Aldo Pietro; Sharma, Arya; Skak-Nielsen, Helle; Torp-Pedersen, Christian; Van Gaal, Luc; Boden InstituteUric Acid as a Risk Factor for Cardiovascular Disease and Mortality in Overweight/Obese Individuals, PLoS One, vol.8, 3, 2013,pp 1-9
2010The weight lowering effect of sibutramine and its impact on serum lipids in cardiovascular high risk patients with and without type 2 diabetes mellitus - an analysis from the SCOUT lead-in periodCaterson, Ian; Andersson, Charlotte; Brendorp, Bente; Finer, Nick; Fosbol, Emil Loldrup; James, Philip; Kober, Lars; Rode, Richard; Sharma, Arya; Torp-Pedersen, Christian; Weeke, Peter; School of Molecular BioscienceThe weight lowering effect of sibutramine and its impact on serum lipids in cardiovascular high risk patients with and without type 2 diabetes mellitus - an analysis from the SCOUT lead-in period, BMC Endocrine Disorders, vol.10, 3,pp 1-9